• Bookmarks
    • Add bookmark
  • Login
  • About Us
  • Investigators
    • Dra. Ibane Abasolo Olaortua
    • Dr. Diego Arango del Corro
    • Dra. Gemma Ariceta Iraola
    • Dra. Eva Baldrich Rubio
    • Dra. Coro Bescós Atin
    • Dr. Joan Castell Conesa
    • Dra. Mari Carmen Domínguez Luengo
    • Dr. Manuel Galiñanes Hernández
    • Dr. José Raúl Herance
    • Dr. Joan López Hellín
    • Dr. Mario Marotta Baleriola
    • Dr. Vicenç Martínez Ibáñez
    • Dra. Anna Meseguer Navarro
    • Dr. Victor Puntes
    • Dr. Joan Sayós Ortega
    • Dr. Simó Schwartz Jr
  • Research Groups
    • Biomedical Research in Digestive Tumors
    • Drug Delivery and Targeting
    • Immune Regulation and Immunotherapy Group
    • Kidney Physiopathology
    • Diagnostic Nanotools for Fast Assay and Biosensor Development.
    • New Technologies and Craniofacial Microsurgery
    • Pharmacokinetic Nanoparticles
    • Reparative Therapy of the Heart
    • The Bioengineering, Cell Therapy and Surgery in Congenital Malformations (Bio-Cell Fetal)
    • Medical Molecular Imaging
  • Preclinical Services
    • In Vitro Experimental Platform
    • In Vivo Experimental Platform
    • Rates & Services
    • Mission, Vision and Quality Policy Statement of FVPR
    • Other services
  • Publications
  • Highlights
  • Contact
Close
  • About Us
  • Investigators
    • Dra. Ibane Abasolo Olaortua
    • Dr. Diego Arango del Corro
    • Dra. Gemma Ariceta Iraola
    • Dra. Eva Baldrich Rubio
    • Dra. Coro Bescós Atin
    • Dr. Joan Castell Conesa
    • Dra. Mari Carmen Domínguez Luengo
    • Dr. Manuel Galiñanes Hernández
    • Dr. José Raúl Herance
    • Dr. Joan López Hellín
    • Dr. Mario Marotta Baleriola
    • Dr. Vicenç Martínez Ibáñez
    • Dra. Anna Meseguer Navarro
    • Dr. Victor Puntes
    • Dr. Joan Sayós Ortega
    • Dr. Simó Schwartz Jr
  • Research Groups
    • Biomedical Research in Digestive Tumors
    • Drug Delivery and Targeting
    • Immune Regulation and Immunotherapy Group
    • Kidney Physiopathology
    • Diagnostic Nanotools for Fast Assay and Biosensor Development.
    • New Technologies and Craniofacial Microsurgery
    • Pharmacokinetic Nanoparticles
    • Reparative Therapy of the Heart
    • The Bioengineering, Cell Therapy and Surgery in Congenital Malformations (Bio-Cell Fetal)
    • Medical Molecular Imaging
  • Preclinical Services
    • In Vitro Experimental Platform
    • In Vivo Experimental Platform
    • Rates & Services
    • Mission, Vision and Quality Policy Statement of FVPR
    • Other services
  • Publications
  • Highlights
  • Contact

All Posts

HomeBlogAll Posts

Perspectives of nano-carrier drug delivery systems to overcome cancer drug resistance in the clinics

12 days ago 10

Anna Ulldemolins1, Joaquin Seras-Franzoso1, Fernanda Andrade2, Diana Rafael2, Ibane Abasolo1,2, Petra Gener1,2, Simo Schwartz Jr1,2 Cancer Drug Resist 2020;3:[Online First]  Review ...

Read more

The potential of nanomedicine to alter cancer stem cell dynamics: the impact of extracellular vesicles

17 days ago 7

Petra Gener , Patricia Gonzalez Callejo, Joaquín Seras-Franzoso, Fernanda Andrade, Diana Rafael, Ibane Abasolo & Simo Schwartz. The presence of highly resistant cancer stem cells (CSCs) within tumors as drivers of metastatic spread has been...

Read more

Extracellular Vesicles as Drug Delivery Systems in Cancer

17 days ago 8

Laia Hernandez-Oller 1 , Joaquin Seras-Franzoso 1, Fernanda Andrade 1,2, Diana Rafael 1,2, Ibane Abasolo 1,2 , Petra Gener 1,2,* and Simo Schwartz Jr. 1,2,* 1 Drug Delivery and Targeting Group, Molecular Biology and Biochemistry Research Centre...

Read more

Novel amphiphilic chitosan micelles as carriers for hydrophobic anticancer drugs

8 October, 2020 5

Andreia Almeida 1, Marco Araújo 2, Ramon Novoa-Carballal 3, Fernanda Andrade 4, Hugo Gonçalves 5, Rui L Reis 3, Marlene Lúcio 6, Simó Schwartz Jr 7, Bruno Sarmento 8 PMID: 32409071 DOI: 10.1016/j.msec.2020.110920 Abstract Chitosan was grafted...

Read more

Simvastatin-loaded polymeric micelles are more effective and less toxic than conventional statins in a pre-clinical model of advanced chronic liver disease

8 October, 2020 1

Diana Hide 1, Mar Gil 2, Fernanda Andrade 3, Diana Rafael 4, Imma Raurell 5, Miren Bravo 6, Aurora Barberá 7, Jordi Gracia-Sancho 8, Víctor Vargas 9, Salvador Augustin 10, Joan Genescà 11, Simo Schwartz Jr 12, Maria Martell 13 PMID: 32681987 DOI...

Read more

Tres investigadores del VHIR reciben una beca de la Asociación Española Contra el Cáncer

30 September, 2020 16
Tres investigadores del VHIR reciben una beca de la Asociación Española Contra el Cáncer

La Asociación Española Contra el Cáncer (AECC) ha presentado hoy, con motivo del Día Mundial de la Investigación en Cáncer, la resolución de las becas para ayudar a la investigación contra el cáncer. Entre los candidatos escogidos se encuentran...

Read more

Cerium oxide nanoparticles may improve hepatocellular carcinoma prognosis

24 February, 2020 383
Cerium oxide nanoparticles may improve hepatocellular carcinoma prognosis

Hepatocellular carcinoma is the most common liver cancer and ranks third in the world in terms of mortality. Its appearance is related to the hepatitis B and C viruses, alcoholism, metabolic diseases of the liver and exposure to certain toxins...

Read more

Intracellular Delivery of Anti-SMC2 Antibodies against Cancer Stem Cells

21 February, 2020 273

Montero S, Seras-Franzoso J, Andrade F, Martinez-Trucharte F, Vilar-Hernández M, Quesada M, Xandri H, Arango D, Abasolo I, Rafael D, Schwartz S Jr. Pharmaceutics. 2020 Feb 21;12(2). pii: E185. doi: 10.3390/pharmaceutics12020185...

Read more

The Biological Potential Hidden in Inclusion Bodies

15 February, 2020 162

Gifre-Renom L, Seras-Franzoso J, Rafael D, Andrade F, Cano-Garrido O, Martinez-Trucharte F, Ugarte-Berzal E, Martens E, Boon L, Villaverde A, Opdenakker G, Schwartz S Jr, Arís A, Garcia-Fruitós E. Pharmaceutics. 2020 Feb 15;12(2). pii: E157. doi...

Read more

An internet of things-based intensity and time-resolved fluorescence reader for point-of-care testing

13 February, 2020 216

O. Alonso,N. Franch,J. Canals,K. Arias-Alpízar,E. de la Serna,E. Baldrich,A. Diéguez Biosensors and Bioelectronics Volume 154, 15 April 2020, 112074 https://doi.org/10.1016/j.bios.2020.112074   Abstract A miniature internet of things...

Read more

Engineering a Nanostructured Nucleolin-Binding Peptide for Intracellular Drug Delivery in Triple-Negative Breast Cancer Stem Cells

5 February, 2020 181

Pesarrodona M, Sanchez-Garcia L, Seras-Franzoso J, Sanchez-Chardi A, Balta-Foix R, Camara-Sanchez P, Gener P, Jara JJ, Pulido D, Serna N, Schwartz S Jr, Royo M, Villaverde A, Abasolo I, Vazquez E ACS Appl Mater Interfaces. 2019 Dec 16. doi...

Read more

Electrochemical POC device for fast malaria quantitative diagnosis in whole blood by using magnetic beads, Poly-HRP and microfluidic paper electrodes

15 January, 2020 225

Gisela Ruiz-Vega, Kevin Arias-Alpízar , Erica de la Serna , Livia Neves Borgheti-Cardoso, Elena Sulleiro, Israel Molina, Xavier Fernandez-Busquets , Adrian Sanchez-Montalva, F. Javier del Campo, Eva Baldrich Biosensors and Bioelectronics.  Volume...

Read more
123…11-20
Search
Categories
  • About-us
  • Biomedical Research in Digestive Tumors
  • Drug Delivery and Targeting
  • events
  • Immune Regulation and Immunotherapy Group
  • Kidney Physiopathology
  • New Technologies and Craniofacial Microsurgery
  • News
  • Pharmacokinetic Nanoparticles
  • Publications
  • The Bioengineering, Cell Therapy and Surgery in Congenital Malformations (Bio-Cell Fetal)
  • Uncategorized
Recent Posts
Tres investigadores del VHIR reciben una beca de la Asociación Española Contra el Cáncer
Tres investigadores del VHIR reciben una beca de la Asociación Española Contra el Cáncer
30 September, 2020by CIBBIM - Nanomedicine0
Cerium oxide nanoparticles may improve hepatocellular carcinoma prognosis
Cerium oxide nanoparticles may improve hepatocellular carcinoma prognosis
24 February, 2020by CIBBIM - Nanomedicine0
Tags
CLINICAL APPLICATION OF NANOMEDICINE ESNAM EUROPEAN SOCIETY FOR NANOMEDICINE INTERNATIONAL SOCIETY OF NANOMEDICINE ISN
Contact Us
CIBBIM-Nanomedicine
Institut de Recerca
Hospital Universitari Vall d'Hebron
Passeig Vall d'Hebron, 119-129-
08035 Barcelona - Spain
Tel: +34 93 489 4055
Fax: +34 93 489 4040
  • Email: info@cibbim.eu


CIBBIM-Nanomedicine laboratories are located within VHIR’s premises (Mediterrània and Collserola buildings, in violet), Bus lines and Metro stations (Line Green (L3); stops of Montbau and Vall d’Hebron) are also indicated.

ACCESS MAP LOCAL
Albertino © 2014 All Rights Reserved
Forgot password?
You can login using your social profile
Problem with login?
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read More